Literature DB >> 16369251

"Aldosterone escape" or refractory hyperaldosteronism?

E Sankaranarayanan Prakash.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16369251      PMCID: PMC1681639     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


× No keyword cloud information.
  6 in total

1.  Effectiveness of aldosterone blockade in patients with diabetic nephropathy.

Authors:  Atsuhisa Sato; Koichi Hayashi; Mitsuhide Naruse; Takao Saruta
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

2.  Renin-angiotensin-aldosterone activation in heart failure, aldosterone escape.

Authors:  Philip Andrew
Journal:  Chest       Date:  2002-08       Impact factor: 9.410

3.  Elevated levels of atrial natriuretic peptide during aldosterone escape.

Authors:  J P Granger; J C Burnett; J C Romero; T J Opgenorth; J Salazar; M Joyce
Journal:  Am J Physiol       Date:  1987-05

4.  Regulation of NHE3, NKCC2, and NCC abundance in kidney during aldosterone escape phenomenon: role of NO.

Authors:  Sharon Turban; Xiao-Yan Wang; Mark A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2003-07-01

5.  Escape from the sodium-retaining effects of mineralocorticoids: is there a role for dopamine?

Authors:  P Coruzzi
Journal:  J Clin Endocrinol Metab       Date:  1994-02       Impact factor: 5.958

Review 6.  The clinical implications of aldosterone escape in congestive heart failure.

Authors:  Allan D Struthers
Journal:  Eur J Heart Fail       Date:  2004-08       Impact factor: 15.534

  6 in total
  1 in total

Review 1.  New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease.

Authors:  Anjay Rastogi; Farid Arman; Setareh Alipourfetrati
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.